FDA briefing documents offered measured support for Moderna's mRNA-1010 flu vaccine ahead of Thursday adcomm, flagging B/Victoria strain gap but calling reactogenicity
The FDA provided tepid support of Moderna’s flu vaccine ahead of an advisory meeting but, more importantly, didn’t appear to raise any major concerns that …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
FDA Staff Weighs In on Potential First mRNA Flu Shot
Moderna flu vaccine wins unanimous support from FDA panel
FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR
New mRNA flu vaccine faces scrutiny ahead of key FDA decision
FDA panel recommends Moderna’s mRNA flu shot for older adults
FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.
Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA…
Moderna's novel vaccine was at the center of dustup with agency earlier this year
The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to…
Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth…
A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier…
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
